Preclinical testing of an ATR inhibitor demonstrates improved response to standard therapies for esophageal cancer - Radiotherapy and Oncology
ATR inhibitor RP-3500 demonstrates safety and early clinical benefit | MD Anderson Cancer Center
Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer | Future Medicinal Chemistry
Ceralasertib (AZD6738) | ≥99%(HPLC) | Selleck | ATM/ATR inhibitor
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
Are ATR Inhibitors The Next Precision Medicine to Improve Cancer Outcomes - CancerConnect
Cancers | Free Full-Text | Targeting the ATR-CHK1 Axis in Cancer Therapy | HTML
Summary of ATR inhibitor-based clinical trials | Download Scientific Diagram
ATM Inhibition | ATR inhibition | ATM Inhibitor Review
Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors - European Urology
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand | Journal of Hematology & Oncology | Full Text
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells | Oncogene
Summary of ATR inhibitor-based clinical trials | Download Scientific Diagram
Frontiers | Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications | Oncology
Penn Medicine MD on Twitter: "The CAPRI Trial of combination ATR and PARP Inhibitor Therapy With AZD6738 and #Olaparib in Recurrent #OvarianCancer is the subject of a new Penn Clinical Briefing at
Analysis Reveals Genomic Effects of a New Cancer Treatment Now in Clinical Trials - Penn Medicine
Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer - Penn Medicine
Clinical trial tests ATR inhibitor in difficult-to-treat cancers | VUMC Reporter | Vanderbilt University
ATR Inhibitors and the Replication of DNA - BioTechniques
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
EMD SERONO | ATRi
Progress towards a clinically-successful ATR inhibitor for cancer therapy - ScienceDirect
Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer - Penn Physician VideoLink
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models | Nature Communications
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors | Journal of Clinical Oncology
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer - Gastroenterology
ATR Inhibitor Combinations Begin to Tackle DNA Damage Repair in Solid Tumors
